Journal
CELL DEATH & DISEASE
Volume 13, Issue 5, Pages -Publisher
SPRINGERNATURE
DOI: 10.1038/s41419-022-04892-9
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81773018, 82104174]
- Natural Science Foundation of Jiangsu Higher Education Institutions of China [20KJB350008]
- Priority Academic Program Development of Jiangsu Higher Education Institutions of China
Ask authors/readers for more resources
The study reveals that FBXO2 acts as an E3 ubiquitin ligase and promotes the degradation of SUN2 protein, which is associated with worse prognosis in ovarian cancer. The transcription factor SOX6 enhances the expression of FBXO2 by recognizing a response element on its promoter. Abnormally high expression of FBXO2 leads to degradation of SUN2 protein, promoting cell proliferation and ultimately contributing to the progression of ovarian cancer.
SAD1/UNC84 domain protein-2 (SUN2) plays a tumor suppressor role in various types of cancer by inhibiting cancer cell proliferation, migration and promoting apoptosis. However, the post-translational regulation of SUN2 and the cellular mechanism responsible for its proteasomal degradation remains largely unknown. Here, we show that FBXO2, an E3 ubiquitin ligase of the F-box proteins (FBPs) family targets glycosylated SUN2 for ubiquitination and degradation via the ubiquitin-proteasome system (UPS). By integrating the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and the Encyclopedia of Cancer Cell Lines (CCLE) databases, we revealed that FBXO2 was selectively highly expressed in ovarian cancer (OV) tissues and cells. Patients with relatively high FBXO2 expression levels were associated with worse prognosis. Manipulation of the expression of FBXO2 affecting ovarian cancer cell proliferation, migration/invasion in vitro, and tumor growth in mice in vivo. The transcription factor SOX6 promoted FBXO2 expression by recognizing a putative response element localized on the promoter region of FBXO2. Abnormally highly expressed FBXO2 recognized and targeted glycosylated SUN2 protein for ubiquitination-depended degradation to prevent cell apoptosis, promote cell proliferation, and ultimately promote the progression of OV. Thus, we revealed a new SOX6-FBXO2-SUN2 axis that contributed to the development of OV, and targeting this axis may represent an effective OV treatment strategy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available